Genome-wide dissection of Mendelian susceptibility to mycobacterial disease
孟德尔对分枝杆菌疾病易感性的全基因组解析
基本信息
- 批准号:8162130
- 负责人:
- 金额:$ 42.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAffectAntibioticsBCG VaccineBiologicalCandidate Disease GeneChildChildhoodClinicalCommunicable DiseasesDefectDevelopmentDiseaseDissectionDominant Genetic ConditionsEmployee StrikesFamilyFamily memberFundingGenesGeneticGenetic CounselingGenetic HeterogeneityGenetic Predisposition to DiseaseGenus MycobacteriumGrantHematopoietic Stem Cell TransplantationHereditary DiseaseHerpes encephalitisHeterogeneityHost DefenseHumanIFNGR1 geneIFNGR2 geneIL12B geneIL12RB1 geneIL12RB2 geneImmunityImmunologic Deficiency SyndromesInborn Genetic DiseasesIndividualInfectionInterferon ReceptorInterferonsInterleukin-12InvestigationJAK2 geneLaboratoriesLifeLightLinkMapsMediatingMethodsMinorityMolecular DiagnosisMolecular GeneticsMutationPathogenesisPathway interactionsPatientsPhysiciansPneumococcal InfectionsPredispositionRecombinant InterferonRecombinantsRecurrenceResearchRoleSTAT1 geneSalmonella infectionsSyndromeTYK2TestingTuberculosisUbiquitinUnited States National Institutes of HealthUrsidae FamilyVariantViralVirulentWorkautosomal recessive traitbasecytokinedisease-causing mutationexomegenome wide association studygenome-widegenome-wide linkageinnovationinsightmicroorganismmycobacterialnovelprotein expressionrecessive genetic traittrait
项目摘要
DESCRIPTION (provided by applicant): Mendelian susceptibility to mycobacterial disease (MSMD) is a primary immunodeficiency syndrome characterized by severe disease caused by weakly virulent mycobacteria, such as BCG vaccines and environmental mycobacteria, in otherwise healthy patients. Patients with MSMD are also vulnerable to tuberculosis and salmonellosis, though other infections are rare. First described clinically in the 1950s, the pathogenesis of MSMD remained unclear until 1996, when its first genetic etiology was deciphered in children with interferon- receptor 1 (IFN-R1) deficiency. Genetic dissection of MSMD over the last fifteen years has identified six morbid genes, including five autosomal (IFNGR1, IFNGR2, STAT1, IL12B, IL12RB1) and one X- linked (NEMO) gene. The high level of allelic heterogeneity at these six loci has led to the definition of up to 13 distinct disorders. The pathogenesis of MSMD in patients with these disorders involves impaired interleukin-12 (IL-12)-dependent IFN- immunity. However, only about half of the 600 patients tested in our laboratory carried any of these genetic defects. We hypothesize that MSMD in other patients results from other monogenic inborn errors of immunity, possibly but not necessarily involving the IL-12-IFN- circuit. A hypothesis-based, candidate gene approach focused on genes involved in the IL-12-IFN- circuit and related to the known MSMD-causing genes is being funded by the NIH grant 1R01AI089970. Therefore, the principal objective of the work described in this application is to identify new MSMD-causing genes by following a complementary, hypothesis-generating, genome-wide (GW) screening approach. In the present, GW approach, we will search for and characterize MSMD-causing genes by GW linkage (for both X-linked and autosomal recessive traits) and GW deep sequencing (by whole-exome sequencing). A novel method of GW linkage has been developed in the lab and whole-exome deep sequencing has been pioneered by our lab for other infectious diseases. Following this approach, we have obtained strong preliminary evidence of five novel MSMD-causing genes, with recessive mutations in X-linked CYBB and autosomal TYK2, JAK2, ISG15, and AP4E1. These five discoveries are very surprising, each in a unique way, and together they neatly illustrate the power of GW approaches and whole-exome sequencing in particular. Our project is therefore highly innovative, feasible, and supported by strong preliminary evidence. From a basic biological standpoint, this research will provide considerable and novel insights into the mechanisms of immunity to mycobacteria. Elucidation of the molecular genetic basis of MSMD will also shed light on the pathogenesis of mycobacterial disease, making it possible to provide molecular diagnoses for patients and genetic counseling for families. This new information will pave the way for the use of IFN- or other cytokines for the treatment of mycobacterial diseases, in addition to antibiotics. Finally, the genetic dissection of MSMD will pave the way for the genetic dissection of severe tuberculosis in otherwise healthy children.
PUBLIC HEALTH RELEVANCE: The known genetic etiologies of Mendelian susceptibility to mycobacterial disease (MSMD) impair interferon (IFN)--mediated immunity. Nearly half the patients with MSMD lack a genetic etiology. We hypothesize that MSMD in these patients also results from inborn errors of immunity, which we aim to identify using hypothesis- free, GW approaches.
描述(由申请人提供):孟德尔对分枝杆菌疾病(MSMD)的易感性是一种原发性免疫缺陷综合症,其特征是由弱毒性分枝杆菌引起的严重疾病,例如BCG疫苗和环境分枝杆菌,在其他健康的患者中。 MSMD患者也很容易受到结核病和沙门氏菌病的影响,尽管其他感染很少。在1950年代,MSMD的发病机理首先在临床上进行描述,直到1996年,其第一个遗传病因在干扰素受体1(IFN-R1)缺陷的儿童中被解密。在过去的十五年中,MSMD的遗传解剖已经确定了六个病态基因,包括五个常染色体(IFNGR1,IFNGR2,STAT1,IL12B,IL12RB1)和一个X-链接(NeMO)基因。这六个基因座的等位基因异质性的高水平导致了多达13种不同疾病的定义。这些疾病患者中MSMD的发病机理涉及白介素12(IL-12)依赖性IFN-免疫性受损。但是,在我们实验室中测试的600名患者中,只有一半携带这些遗传缺陷。我们假设其他患者的MSMD是由于其他单基因先天性误差而导致的,可能但不一定涉及IL-12-IFN-回路。一种基于假设的候选基因方法,该方法重点介绍了IL-12-IFN-回路涉及的基因,并且与已知的MSMD引起基因有关,这是由NIH Grant 1R01AI089970资助的。因此,本应用中描述的工作的主要目标是通过遵循互补的,假设生成的,全基因组(GW)筛查方法来识别新的引起MSMD的基因。在目前的GW方法中,我们将通过GW链接(用于X连锁和常染色体隐性性状)和GW深度测序(通过全符号测序)来搜索并表征MSMD引起的基因。实验室已经开发了一种新型的GW连锁方法,我们的实验室为其他传染病率先提出了全面的深层测序。遵循这种方法,我们获得了五个新型引起MSMD的基因的强烈初步证据,X连锁CYBB和常染色体TYK2,JAK2,ISG15和AP4E1中有隐性突变。这五个发现非常令人惊讶,每种发现都以独特的方式,它们整洁地说明了GW方法的力量,尤其是整个外观测序的力量。因此,我们的项目具有很高的创新性,可行性,并且得到了强有力的初步证据的支持。从基本的生物学角度来看,这项研究将为对分枝杆菌的免疫机制提供大量新颖的见解。阐明MSMD的分子遗传基础还将阐明分枝杆菌疾病的发病机理,从而为患者提供分子诊断和家庭的遗传咨询。除抗生素外,这些新信息还将为使用IFN或其他细胞因子治疗分枝杆菌疾病铺平道路。最后,MSMD的遗传解剖会为其他健康儿童的严重结核病的遗传解剖铺平道路。
公共卫生相关性:孟德尔对分枝杆菌疾病(MSMD)易感性的已知遗传病因损害了干扰素(IFN) - 介导的免疫力。 MSMD患者几乎一半缺乏遗传病因。我们假设这些患者中的MSMD也是由于先天免疫力而引起的,我们旨在使用无假设的GW方法来识别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jean-Laurent Casanova其他文献
Jean-Laurent Casanova的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jean-Laurent Casanova', 18)}}的其他基金
Inborn errors of immunity in patients with life-threatening COVID-19
危及生命的 COVID-19 患者先天性免疫缺陷
- 批准号:
10655372 - 财政年份:2021
- 资助金额:
$ 42.25万 - 项目类别:
Inborn errors of immunity in patients with life-threatening COVID-19
危及生命的 COVID-19 患者先天性免疫缺陷
- 批准号:
10278180 - 财政年份:2021
- 资助金额:
$ 42.25万 - 项目类别:
Inborn errors of immunity in patients with life-threatening COVID-19
危及生命的 COVID-19 患者先天性免疫缺陷
- 批准号:
10449276 - 财政年份:2021
- 资助金额:
$ 42.25万 - 项目类别:
Molecular and cellular basis of epidermodysplasia verruciformis
疣状表皮发育不良的分子和细胞基础
- 批准号:
10561607 - 财政年份:2020
- 资助金额:
$ 42.25万 - 项目类别:
Monogenic basis of resistance to SARS-CoV2 and predisposition to severe COVID-19
抗 SARS-CoV2 的单基因基础和严重 COVID-19 的易感性
- 批准号:
10159675 - 财政年份:2020
- 资助金额:
$ 42.25万 - 项目类别:
Molecular and cellular basis of epidermodysplasia verruciformis
疣状表皮发育不良的分子和细胞基础
- 批准号:
10352425 - 财政年份:2020
- 资助金额:
$ 42.25万 - 项目类别:
Molecular and cellular basis of epidermodysplasia verruciformis
疣状表皮发育不良的分子和细胞基础
- 批准号:
9887337 - 财政年份:2020
- 资助金额:
$ 42.25万 - 项目类别:
相似国自然基金
多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
- 批准号:32301424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
苏打盐碱湿地干湿交替对抗生素迁移转化的影响机制
- 批准号:42301134
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
三峡库区沉积物中微塑料和抗生素复合污染对N2O排放过程的影响机制
- 批准号:52300244
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境兽用抗生素暴露对儿童心血管危险因素聚集影响及SCAP-SREBP脂代谢通路基因甲基化调控机制研究
- 批准号:82373593
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
抗生素对不同生长阶段蓝藻光合电子传递和生理代谢的影响及分子机制研究
- 批准号:52300219
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease
定义莱姆病肽聚糖诱导的病理生理学的宿主和病原体决定因素
- 批准号:
10566961 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
CD19 靶向 CAR-T 细胞治疗后的免疫球蛋白替代疗法和感染并发症
- 批准号:
10732195 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Immune recognition of Klebsiella pneumoniae O2v1 and O2v2 O-antigen subtypes
肺炎克雷伯菌 O2v1 和 O2v2 O 抗原亚型的免疫识别
- 批准号:
10739041 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别:
Impact of Tetracycline Antibiotics on Skeletal Maturation
四环素抗生素对骨骼成熟的影响
- 批准号:
10660594 - 财政年份:2023
- 资助金额:
$ 42.25万 - 项目类别: